- Corporate Officers - S
- Schiff Andrew N
Insider Trading History of Schiff Andrew N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schiff Andrew N since 2015.
This trader's CIK number is 1172252.
At the time of last reporting, Schiff Andrew N was the Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
Note that in the past
SCHIFF ANDREW N also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Zeltiq Aesthetics Inc (ZLTQ) by Schiff Andrew N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ZLTQ | 0 | $0 | 500,000 | $18,196,000 | 0 | $0 |
| 2015 | ZLTQ | 0 | $0 | 532,782 | $16,382,433 | 0 | $0 |
Yearly summary of insider trading at Aravive, Inc. (VSAR) by Schiff Andrew N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | VSAR | 145,000 | $2,501,250 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Schiff Andrew N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ACRS | 0 | $0 | 0 | $0 | 4,793 | $0 |
| 2024 | ACRS | 0 | $0 | 0 | $0 | 4,660 | $0 |
| 2023 | ACRS | 0 | $0 | 0 | $0 | 4,507 | $0 |
| 2022 | ACRS | 0 | $0 | 165,639 | $2,726,085 | 3,356 | $0 |
| 2020 | ACRS | 0 | $0 | 0 | $0 | 16,209 | $0 |
| 2017 | ACRS | 108,601 | $2,499,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Agile Therapeutics Inc (AGRX) by Schiff Andrew N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | AGRX | 811,966 | $4,750,001 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Schiff Andrew N:
1. Zeltiq Aesthetics Inc (ZLTQ)
2. Aravive, Inc. (VSAR)
3. Aclaris Therapeutics, Inc. (ACRS)
4. Agile Therapeutics Inc (AGRX)
Table 1. Insider trading of Zeltiq Aesthetics Inc (ZLTQ) by Schiff Andrew N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-08-11 | ZLTQ | Sale | 500,000 | 36.39 | 18,196,000 |
| 2015-12-08 | ZLTQ | Sale | 25,300 | 30.17 | 763,250 |
| 2015-12-07 | ZLTQ | Sale | 7,482 | 30.01 | 224,549 |
| 2015-11-23 | ZLTQ | Sale | 100,000 | 31.46 | 3,146,100 |
| 2015-11-20 | ZLTQ | Sale | 155,992 | 30.27 | 4,721,721 |
| 2015-11-18 | ZLTQ | Sale | 194,008 | 30.94 | 6,002,413 |
| 2015-11-19 | ZLTQ | Sale | 50,000 | 30.49 | 1,524,400 |
Table 2. Insider trading of Aravive, Inc. (VSAR) by Schiff Andrew N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-01-27 | VSAR | Buy | 145,000 | 17.25 | 2,501,250 |
Table 3. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Schiff Andrew N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-06 | ACRS | Option Ex | 4,793 | .00 | 0 |
| 2024-06-01 | ACRS | Option Ex | 4,660 | .00 | 0 |
| 2023-06-02 | ACRS | Option Ex | 4,507 | .00 | 0 |
| 2022-10-24 | ACRS | Sale | 14,616 | 17.01 | 248,588 |
| 2022-10-25 | ACRS | Sale | 12,018 | 17.02 | 204,522 |
| 2022-10-26 | ACRS | Sale | 14,540 | 17.00 | 247,252 |
| 2022-10-17 | ACRS | Sale | 19,944 | 16.05 | 320,081 |
| 2022-10-18 | ACRS | Sale | 32,093 | 16.89 | 542,018 |
| 2022-10-07 | ACRS | Sale | 7,324 | 16.16 | 118,348 |
| 2022-10-06 | ACRS | Sale | 37,839 | 16.54 | 625,743 |
| 2022-10-04 | ACRS | Sale | 7,700 | 16.01 | 123,261 |
| 2022-06-17 | ACRS | Sale | 19,565 | 15.14 | 296,272 |
| 2022-06-03 | ACRS | Option Ex | 3,356 | .00 | 0 |
| 2020-06-06 | ACRS | Option Ex | 7,333 | .00 | 0 |
| 2020-03-02 | ACRS | Option Ex | 8,876 | .00 | 0 |
| 2017-08-16 | ACRS | Buy | 108,601 | 23.02 | 2,499,995 |
Table 4. Insider trading of Agile Therapeutics Inc (AGRX) by Schiff Andrew N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-01-23 | AGRX | Buy | 811,966 | 5.85 | 4,750,001 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schiff Andrew N
(Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.